Clinical Trial Update: Crestor Versus Placebo in Subjects With Heart Failure [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating rosuvastatin (Crestor) versus placebo in patients with heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• CRESTOR (Rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Heart Failure | Phase 3 | Status: COMPLETED